Therefore, we speculate that APS may decrease the secretion of pro-inflammatory cytokines by preventing the initiation of the TLR4/MyD88/NF-κB pathway, which may be the main approach to ameliorate gut inflammation and injury caused by DSS. This evidence concerns the gene NFKB1 and autoimmune polyendocrinopathy.